3.300SEK+2.17%Mkt Cap: 131.64M SEKP/E: —Last update: 2026-05-13
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)3.00
PEG—
P/B0.77
P/S0.28
EV/EBITDA6.82
EV/Revenue0.70
EPS (TTM)-0.03
EPS (Forward)1.13
Cash Flow & Leverage
FCF Yield14.01%
FCF Margin3.86%
Operating CF829.00K SEK
CapEx (TTM)4.96M SEK
Net Debt/EBITDA4.14
Net Debt203.50M SEK
Technical
SMA 503.811 (-13.4%)
SMA 2005.004 (-34.1%)
Beta0.17
S&P 52W Chg24.23%
Avg Vol (30d)53.82K
Avg Vol (10d)67.58K
Technical Indicators
RSI (14)35.8
MACD-0.1889
MACD Signal-0.1546
MACD Hist.-0.0343
BB Upper4.212 SEK
BB Middle3.647 SEK
BB Lower3.081 SEK
BB Width31.00%
ATR (14)0.2178 SEK
Vol Ratio (20d)0.18x
52W Range
3.1402% of range10.60
52W High10.60 SEK
52W Low3.140 SEK
Profitability
Gross Margin43.66%
EBITDA Margin10.27%
Profit Margin-0.77%
Oper. Margin-1.38%
ROE-2.24%
ROA-0.80%
Revenue Growth-10.00%
Earnings Growth—
Balance Sheet
Debt/Equity1.33
Current Ratio1.06
Quick Ratio0.69
Book Value/Sh4.416 SEK
Cash/Share0.4760 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield0.73%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Ownership
Shares Out.38.83M
Float22.80M
Insiders38.56%
Institutions54.28%
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)3.800 SEK
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Company
Market Cap131.64M SEK
Enterprise Value335.14M SEK
Revenue (TTM)478.39M SEK
Gross Profit213.81M SEK
Net Income (TTM)-3.75M SEK
Revenue/Share12.30 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees200
Last Price3.300 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—